News
Investor's Business Daily on MSN13h
Stocks To Watch: Capricor Therapeutics Sees RS Rating Rise To 86Capricor TherapeuticsCAPR just hit that mark, with a jump from 69 to 86 Thursday. Please watch the video at Investors.com - ...
Pomerantz LLP is investigating claims on behalf of investors of Capricor Therapeutics, Inc. (“Capricor” or the “Company”) (NASDAQ: CAPR). Such investors are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback